Surgery Partners SGRY
$26.78 +$0.09 (+0.34%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $26.78 0.00%
Open$26.64
Prev close$26.69
Day range$26.62 – $26.96
Volume1.11M
Market cap$3.50B
P/E (TTM)–
Dividend yield–
SGRY Stock News
Headlines matching Surgery Partners or the SGRY ticker, most recent first.
- RBC Capital Maintains Surgery Partners(SGRY.US) With Buy Rating, Maintains Target Price $19
- BofA Securities Maintains Surgery Partners(SGRY.US) With Buy Rating, Raises Target Price to $20 Positive
- TD Cowen Maintains Surgery Partners(SGRY.US) With Buy Rating, Maintains Target Price $19
- J.P. Morgan Maintains Surgery Partners(SGRY.US) With Hold Rating, Raises Target Price to $15 Positive
- Barclays Maintains Surgery Partners(SGRY.US) With Hold Rating, Maintains Target Price $14
- Benchmark Co. Maintains Surgery Partners(SGRY.US) With Buy Rating, Maintains Target Price $24
- TD Cowen Initiates Surgery Partners(SGRY.US) With Buy Rating, Announces Target Price $19
- Cantor Fitzgerald Maintains Surgery Partners(SGRY.US) With Buy Rating, Cuts Target Price to $18 Negative
- A Quick Look at Today's Ratings for Surgery Partners(SGRY.US), With a Forecast Between $18 to $19
- Mizuho Securities Maintains Surgery Partners(SGRY.US) With Buy Rating, Raises Target Price to $19 Positive
- Jefferies Maintains Surgery Partners(SGRY.US) With Buy Rating, Raises Target Price to $17 Positive
- KeyBanc Maintains Surgery Partners(SGRY.US) With Hold Rating
- TD Cowen Maintains Surgery Partners(SGRY.US) With Buy Rating, Maintains Target Price $20
- TD Cowen Maintains Surgery Partners(SGRY.US) With Buy Rating, Cuts Target Price to $17 Negative
- BofA Securities Maintains Surgery Partners(SGRY.US) With Buy Rating, Maintains Target Price $17.5
No comments yet — be the first to weigh in on SGRY.
Sign in to join the discussion.